Brian Adams - Net Worth and Insider Trading
Brian Adams Net Worth
The estimated net worth of Brian Adams is at least $2 Million dollars as of 2024-12-28. Brian Adams is the Chief Legal Officer of Relay Therapeutics Inc and owns about 321,907 shares of Relay Therapeutics Inc (RLAY) stock worth over $1 Million. Brian Adams is also the General Counsel and Secretary of Keryx Biopharmaceuticals Inc and owns about 126,069 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $423,592. Details can be seen in Brian Adams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Adams has not made any transactions after 2024-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Adams
Brian Adams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Adams owns 2 companies in total, including Relay Therapeutics Inc (RLAY) , and Keryx Biopharmaceuticals Inc (KERX) .
Click here to see the complete history of Brian Adams’s form 4 insider trades.
Insider Ownership Summary of Brian Adams
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RLAY | Relay Therapeutics Inc | 2024-10-28 | General Counsel |
| KERX | Keryx Biopharmaceuticals Inc | 2018-02-15 | General Counsel and Secretary |
Brian Adams Latest Holdings Summary
Brian Adams currently owns a total of 2 stocks. Among these stocks, Brian Adams owns 321,907 shares of Relay Therapeutics Inc (RLAY) as of October 28, 2024, with a value of $1 Million and a weighting of 76.82%. Brian Adams also owns 126,069 shares of Keryx Biopharmaceuticals Inc (KERX) as of February 15, 2018, with a value of $423,592 and a weighting of 23.18%.
Latest Holdings of Brian Adams
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RLAY | Relay Therapeutics Inc | 2024-10-28 | 321,907 | 4.36 | 1,403,515 |
| KERX | Keryx Biopharmaceuticals Inc | 2018-02-15 | 126,069 | 3.36 | 423,592 |
Holding Weightings of Brian Adams
Brian Adams Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Adams has made a total of 32 transactions in Relay Therapeutics Inc (RLAY) over the past 5 years, including 1 buys and 31 sells. The most-recent trade in Relay Therapeutics Inc is the sale of 1,632 shares on October 28, 2024, which brought Brian Adams around $9,890.
According to the SEC Form 4 filings, Brian Adams has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 5,652 shares on February 15, 2018, which brought Brian Adams around $27,186.
Insider Trading History of Brian Adams
- 1
Brian Adams Trading Performance
GuruFocus tracks the stock performance after each of Brian Adams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian Adams is -9.05%. GuruFocus also compares Brian Adams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian Adams within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brian Adams's insider trading performs compared to the benchmark.
Performance of Brian Adams
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.86 | | | | | |
| Relative Return to S&P 500(%) | -17.97 | | | | | |
Brian Adams Ownership Network
Brian Adams Owned Company Details
What does Relay Therapeutics Inc do?
Who are the key executives at Relay Therapeutics Inc?
Brian Adams is the General Counsel of Relay Therapeutics Inc. Other key executives at Relay Therapeutics Inc include director & President and CEO Sanjiv Patel , Vice President & Finance Thomas Catinazzo , and See remarks Peter Rahmer .
Relay Therapeutics Inc (RLAY) Insider Trades Summary
Over the past 18 months, Brian Adams made 10 insider transaction in Relay Therapeutics Inc (RLAY) with a net sale of 9,679. Other recent insider transactions involving Relay Therapeutics Inc (RLAY) include a net sale of 131,867 shares made by Peter Rahmer , a net sale of 43,738 shares made by Thomas Catinazzo , and a net sale of 17,892 shares made by Donald A Bergstrom .
In summary, during the past 3 months, insiders sold 115,043 shares of Relay Therapeutics Inc (RLAY) in total and bought 0 shares, with a net sale of 115,043 shares. During the past 18 months, 389,882 shares of Relay Therapeutics Inc (RLAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 389,882 shares.
Relay Therapeutics Inc (RLAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relay Therapeutics Inc Insider Transactions
Brian Adams Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Adams. You might contact Brian Adams via mailing address: 750 Lexington Avenue, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
